phenytoin has been researched along with tacrolimus in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 5 (23.81) | 29.6817 |
2010's | 7 (33.33) | 24.3611 |
2020's | 7 (33.33) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Mosley, CA; Thompson, PA | 1 |
Andres, A; Carreño, A; Cubas, A; Delgado, M; Dominguez-Gil, B; Herrero, JC; Latorre, A; Manzanares, C; Morales, E; Morales, JM; Moreno, M | 1 |
Arriba, L; de Andrés, A; Hernández, G; Lucas, M | 1 |
Evans, CG; Formea, CM; Karlix, JL | 1 |
Koike, H; Oki, Y; Sobue, G | 1 |
Hanatani, A; Kotake, T; Morishita, H; Nakatani, T; Ochi, H; Takada, M; Ueda, T; Wada, K | 1 |
Matsumoto, H; Ugawa, Y | 1 |
Bax, K; Filler, G; Rieder, MJ; Tijssen, J | 1 |
Hamid, M; McGowan, M; Meaney, CJ; O'Connor, M; Su, W | 1 |
Asch, WS; Belfield, KD; Cohen, EA; Harkness, TM | 1 |
Inany, M; Lee, SJ; Sharma, A; Wahby, KA | 1 |
Bernard, SA; Boilson, BA; Lemke, AI; Razonable, RR | 1 |
Carroll, E; McCabe, D; Sindelar, M | 2 |
da Silva Dal Pizzol, T; de Oliveira, LM | 1 |
4 review(s) available for phenytoin and tacrolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.
Topics: Anticonvulsants; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Epilepsy; Female; Gingival Overgrowth; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Phenytoin; Tacrolimus; Time Factors | 2000 |
Altered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.
Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Oxidoreductases, N-Demethylating; Phenytoin; Tacrolimus | 2005 |
[Adverse effects of therapeutic drugs on peripheral nervous system].
Topics: Anti-HIV Agents; Anticonvulsants; Antineoplastic Agents; Antitubercular Agents; Cisplatin; Dose-Response Relationship, Drug; Early Diagnosis; Humans; Immunosuppressive Agents; Paclitaxel; Peripheral Nervous System Diseases; Phenytoin; Tacrolimus; Thalidomide; Vincristine | 2007 |
17 other study(ies) available for phenytoin and tacrolimus
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Tacrolimus-phenytoin interaction.
Topics: Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Middle Aged; Phenytoin; Tacrolimus | 1996 |
Clinical management of tacrolimus drug interactions in renal transplant patients.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Interactions; Erythromycin; Female; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Phenytoin; Postoperative Complications; Rifampin; Tacrolimus | 1999 |
Drug interactions between tacrolimus and phenytoin in Japanese heart transplant recipients: 2 case reports.
Topics: Adult; Anticonvulsants; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Japan; Phenytoin; Tacrolimus | 2007 |
[Drug induced peripheral neuropathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-HIV Agents; Antibodies, Monoclonal; Anticonvulsants; Antineoplastic Agents; Antiprotozoal Agents; Antirheumatic Agents; Antitubercular Agents; Colchicine; Gout Suppressants; Humans; Immunosuppressive Agents; Infliximab; Interferon-alpha; Metronidazole; Peripheral Nervous System Diseases; Phenytoin; Tacrolimus | 2012 |
Rapid resolution of tacrolimus intoxication-induced AKI with a corticosteroid and phenytoin.
Topics: Child; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Phenytoin; Tacrolimus | 2014 |
Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient.
Topics: Darunavir; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Male; Middle Aged; Phenytoin; Renal Dialysis; Ritonavir; Tacrolimus | 2019 |
Clinical Implications of Unique Drug Interaction Between Extended Release Tacrolimus and Phenytoin.
Topics: Anticonvulsants; Calcineurin Inhibitors; Delayed-Action Preparations; Drug Interactions; Female; Graft Rejection; Humans; Kidney Transplantation; Middle Aged; Phenytoin; Tacrolimus | 2020 |
Use of phenytoin for treatment of tacrolimus toxicity with superimposed sepsis.
Topics: Adult; Cytochrome P-450 CYP1A2 Inducers; Female; Humans; Immunosuppressive Agents; Phenytoin; Sepsis; Tacrolimus; Treatment Outcome | 2020 |
Phenytoin to expedite sirolimus and tacrolimus elimination.
Topics: Humans; Immunosuppressive Agents; Kidney Transplantation; Phenytoin; Sirolimus; Tacrolimus | 2022 |
Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.
Topics: Aged; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Female; Humans; Phenytoin; Ritonavir; SARS-CoV-2; Tacrolimus | 2023 |
Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
Topics: Humans; Phenytoin; Ritonavir; Tacrolimus | 2023 |
Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
Topics: Humans; Phenytoin; Ritonavir; Tacrolimus | 2023 |